Discontinuation report ACT RANITIDINE
Report ID | 115079 |
Drug Identification Number | 02248570 |
Brand name | ACT RANITIDINE |
Common or Proper name | RANITIDINE 150MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 Bot, 60 U/D, 100, 500 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-05-08 |
Actual discontinuation date | 2020-05-08 |
Remaining supply date | 2020-05-08 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-05-14 | French | Compare |
v1 | 2020-05-14 | English | Compare |
Showing 1 to 2 of 2